Memantine and blood creatine phosphokinase increased Patient Reports February 12, 2012

Memantine Side Effects Report #5093442-5
Memantine side effect was reported by a Health Professional from GERMANY on Aug 17, 2006. Female patient, 70 years of age, weighting 165.3 lb, was diagnosed with intentional overdose and was treated with Memantine. After drug was administered, patient experienced the following side effects: aspiration, atrioventricular block first degree, blood creatine phosphokinase increased, bradycardia, coma, vomiting. Memantine dosage: 1000 MG ONCE PO. During the same period patient was treated with MELPERON, REMERON, VENLAFAXINE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5107766-6
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 29, 2006. Female patient, 70 years of age, weighting 165.3 lb, was diagnosed with intentional overdose and was treated with Memantine. After drug was administered, patient experienced the following side effects: aspiration, atrioventricular block first degree, blood creatine phosphokinase increased, bradycardia, c-reactive protein increased, coma, intentional overdose, vomiting. Memantine dosage: 1000 MG ONCE PO. During the same period patient was treated with MELPERON, REMERON, VENLAFAXINE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5223532-5
Memantine side effect was reported by a Physician from UNITED STATES on Jan 18, 2007. Female patient, 88 years of age, weighting 114.0 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase decreased, anaemia, asthenia, blood albumin increased, blood amylase increased, blood creatine phosphokinase increased, blood pressure systolic increased, brain natriuretic peptide increased, cardiac failure congestive. Memantine dosage: 28 MG QD PO. During the same period patient was treated with DONEPEZIL HYDROCHLORIDE, FOLIC ACID, MIRTAZAPINE, RISEDRONATE, DOCUSATE, RANITIDINE, TRIMETHOPRIM, DARVOCET. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4622055-1
Memantine side effect was reported by a Physician from on Mar 11, 2005. Male patient, 85 years of age, weighting 153.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood albumin increased, blood creatine phosphokinase increased, blood glucose increased, blood phosphorus decreased, blood phosphorus increased, blood urine present, bundle branch block left, bundle branch block right, dehydration. Memantine dosage: 20 MG QD PO. During the same period patient was treated with VITAMIN B6, VITAMIN B, VITAMIN C, VITAMIN E. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5394930-4
Memantine side effect was reported by a Health Professional from GERMANY on July 09, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type, fatigue, social avoidant behaviour and was treated with Memantine. After drug was administered, patient experienced the following side effects: arteriospasm coronary, blood creatine phosphokinase increased, cardiogenic shock, chest pain , coronary artery stenosis, dizziness , dyspnoea, ejection fraction decreased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with DILTIAZEM, DONEPEZIL, RITALIN, METOPROLOL EXTENDED, SIMVASTATIN, GEMFIBROZIL, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5246155-0
Memantine side effect was reported by a Health Professional from FRANCE on Feb 01, 2007. Female patient, 81 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type, arrhythmia , prophylaxis and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, blood sodium increased, bundle branch block left, diabetic hyperosmolar coma, fluid intake reduced, intracardiac thrombus, liver disorder, multi-organ failure, neutrophil count increased. Memantine dosage: unknown. During the same period patient was treated with SOTALOL, KARDEGIC, EXELON. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5246154-9
Memantine side effect was reported by a Health Professional from JAPAN on Feb 08, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, c-reactive protein increased, depressed level of consciousness. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5633808-5
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Jan 30, 2008. Male patient, 77 years of age, weighting 127.9 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, altered state of consciousness, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, blood magnesium increased, blood sodium decreased, blood urea increased. Memantine dosage: unknown. During the same period patient was treated with ASPIRIN, AZULENE SULFONATE, CILOSTAZOL, ANTIBIOTICS, NIFEDIPINE, ETHYL ICOSAPENTATE, RILMAZAFONE HYDROCHLORIDE, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Memantine Side Effects Report #4767726-1
Memantine side effect was reported by a Health Professional from GERMANY on Aug 29, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTOZOLAM. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4963734-6
Memantine side effect was reported by a Health Professional from JAPAN on Oct 03, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5036482-4
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, bile duct stone, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5513946-8
Memantine side effect was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 70 years of age, weighting 170.6 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anoxic encephalopathy, arteriosclerosis, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood creatinine increased, blood gases abnormal, blood glucose increased, blood phosphorus increased, blood urine present. Memantine dosage: 28 MG QD PO. During the same period patient was treated with ARICEPT, CALTRATE, CELEXA, FOLBIC, VITAMIN CAP, PLAQUENIL, VITAMIN E. Patient was hospitalized. Patient died on 07/18/2007.

Memantine Side Effects Report #5874781-4
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 19, 2008. Male patient, 65 years of age, weighting 125.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coma, convulsion, dyskinesia, excoriation, hypophagia, infection , somnolence. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL; 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESYLATE, RISPERIDONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5924685-3
Memantine side effect was reported by a Health Professional from GERMANY on Oct 08, 2008. Male patient, 65 years of age, weighting 125.7 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, coma, decubitus ulcer, disease progression, dyskinesia, epilepsy , excoriation, infection , somnolence. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BROTIZOLAM, AMLODIPINE BESYLATE, RISPERIDONE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5989142-7
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Nov 28, 2008. Female patient, 65 years of age, weighting 113.5 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, body temperature increased, choking , fall , immobile, muscle rigidity, pallor, pneumonia aspiration, tremor. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PRAVASTATIN, FLUVOXAMINE MALEATE, FLUTICASONE PROPIONATE, PROCATEROL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5179927-1
Memantine side effect was reported by a Health Professional from FRANCE on Nov 29, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.

Memantine Side Effects Report #5193633-9
Memantine side effect was reported by a Health Professional from GERMANY on Dec 14, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.

Memantine Side Effects Report #5196547-3
Memantine side effect was reported by a Health Professional from FRANCE on Dec 14, 2006. Female patient was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with GALANTAMINE HYDROBROMIDE, EQUANIL. Patient recovered.

Memantine Side Effects Report #5172420-1
Memantine side effect was reported by a Health Professional from FRANCE on Nov 14, 2006. Female patient, 70 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Memantine dosage: unknown. During the same period patient was treated with GALANTAMINE HYDROBROMIDE. Patient recovered.